Immune recovery in peripheral blood after congenic purified hematopoietic stem cell transplantation
. | Total . | . | . | Donor-type . | . | Host-type . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
. | CD4+ . | CD8+ . | B220+ . | CD4+ . | CD8+ . | CD4+ . | CD8+ . | ||||
Before transplantation | 773 ± 147 | 379 ± 69 | 2912 ± 714 | — | — | — | — | ||||
Day + 28 | |||||||||||
400 KTLS | 429 ± 98* | 265 ± 79 | 77 ± 60‡ | 2 ± 1† | 1 ± 1† | 427 ± 98* | 264 ± 78 | ||||
1000 KTLS | 548 ± 100 | 292 ± 101 | 465 ± 267 | 10 ± 6 | 5 ± 3 | 538 ± 97 | 287 ± 99 | ||||
5000 KTLS | 653 ± 213 | 316 ± 134 | 1481 ± 464 | 65 ± 71 | 23 ± 20 | 588 ± 176 | 292 ± 125 | ||||
Day + 35 | |||||||||||
400 KTLS | 633 ± 202† | 383 ± 122 | 438 ± 364‡ | 48 ± 31‡ | 13 ± 8‡ | 431 ± 98† | 278 ± 83 | ||||
1000 KTLS | 866 ± 143 | 412 ± 135 | 1201 ± 482 | 152 ± 80 | 45 ± 26 | 714 ± 114 | 367 ± 112 | ||||
5000 KTLS | 1028 ± 214 | 458 ± 137 | 2897 ± 540 | 366 ± 127 | 115 ± 38 | 662 ± 149 | 342 ± 135 | ||||
Day + 42 | |||||||||||
400 KTLS | 1130 ± 198† | 575 ± 135 | 1556 ± 1408‡ | 401 ± 150‡ | 113 ± 44‡ | 729 ± 185 | 462 ± 155 | ||||
1000 KTLS | 1345 ± 211 | 628 ± 118 | 3056 ± 839 | 645 ± 151 | 208 ± 56 | 700 ± 123 | 420 ± 111 | ||||
5000 KTLS | 1563 ± 349 | 700 ± 184 | 4651 ± 845 | 937 ± 263 | 320 ± 101 | 626 ± 102 | 379 ± 89 | ||||
Day + 56 | |||||||||||
400 KTLS | 1486 ± 640 | 724 ± 328 | 2571 ± 2575* | 929 ± 464† | 304 ± 169† | 558 ± 219 | 420 ± 191 | ||||
1000 KTLS | 1371 ± 282 | 641 ± 83 | 2543 ± 1317 | 857 ± 187 | 317 ± 71 | 514 ± 159 | 324 ± 57 | ||||
5000 KTLS | 1816 ± 353 | 819 ± 158 | 4973 ± 1015 | 1387 ± 272 | 503 ± 103 | 429 ± 90 | 315 ± 97 | ||||
Day + 70 | |||||||||||
400 KTLS | 2109 ± 619* | 983 ± 302† | 5721 ± 4035* | 1561 ± 486† | 547 ± 185† | 548 ± 174 | 436 ± 153† | ||||
1000 KTLS | 1597 ± 507 | 680 ± 154 | 4316 ± 2137 | 1189 ± 434 | 413 ± 139 | 408 ± 113 | 267 ± 28 | ||||
5000 KTLS | 2476 ± 521 | 1111 ± 234 | 8148 ± 1873 | 2048 ± 441 | 802 ± 172 | 428 ± 84 | 309 ± 87 |
. | Total . | . | . | Donor-type . | . | Host-type . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
. | CD4+ . | CD8+ . | B220+ . | CD4+ . | CD8+ . | CD4+ . | CD8+ . | ||||
Before transplantation | 773 ± 147 | 379 ± 69 | 2912 ± 714 | — | — | — | — | ||||
Day + 28 | |||||||||||
400 KTLS | 429 ± 98* | 265 ± 79 | 77 ± 60‡ | 2 ± 1† | 1 ± 1† | 427 ± 98* | 264 ± 78 | ||||
1000 KTLS | 548 ± 100 | 292 ± 101 | 465 ± 267 | 10 ± 6 | 5 ± 3 | 538 ± 97 | 287 ± 99 | ||||
5000 KTLS | 653 ± 213 | 316 ± 134 | 1481 ± 464 | 65 ± 71 | 23 ± 20 | 588 ± 176 | 292 ± 125 | ||||
Day + 35 | |||||||||||
400 KTLS | 633 ± 202† | 383 ± 122 | 438 ± 364‡ | 48 ± 31‡ | 13 ± 8‡ | 431 ± 98† | 278 ± 83 | ||||
1000 KTLS | 866 ± 143 | 412 ± 135 | 1201 ± 482 | 152 ± 80 | 45 ± 26 | 714 ± 114 | 367 ± 112 | ||||
5000 KTLS | 1028 ± 214 | 458 ± 137 | 2897 ± 540 | 366 ± 127 | 115 ± 38 | 662 ± 149 | 342 ± 135 | ||||
Day + 42 | |||||||||||
400 KTLS | 1130 ± 198† | 575 ± 135 | 1556 ± 1408‡ | 401 ± 150‡ | 113 ± 44‡ | 729 ± 185 | 462 ± 155 | ||||
1000 KTLS | 1345 ± 211 | 628 ± 118 | 3056 ± 839 | 645 ± 151 | 208 ± 56 | 700 ± 123 | 420 ± 111 | ||||
5000 KTLS | 1563 ± 349 | 700 ± 184 | 4651 ± 845 | 937 ± 263 | 320 ± 101 | 626 ± 102 | 379 ± 89 | ||||
Day + 56 | |||||||||||
400 KTLS | 1486 ± 640 | 724 ± 328 | 2571 ± 2575* | 929 ± 464† | 304 ± 169† | 558 ± 219 | 420 ± 191 | ||||
1000 KTLS | 1371 ± 282 | 641 ± 83 | 2543 ± 1317 | 857 ± 187 | 317 ± 71 | 514 ± 159 | 324 ± 57 | ||||
5000 KTLS | 1816 ± 353 | 819 ± 158 | 4973 ± 1015 | 1387 ± 272 | 503 ± 103 | 429 ± 90 | 315 ± 97 | ||||
Day + 70 | |||||||||||
400 KTLS | 2109 ± 619* | 983 ± 302† | 5721 ± 4035* | 1561 ± 486† | 547 ± 185† | 548 ± 174 | 436 ± 153† | ||||
1000 KTLS | 1597 ± 507 | 680 ± 154 | 4316 ± 2137 | 1189 ± 434 | 413 ± 139 | 408 ± 113 | 267 ± 28 | ||||
5000 KTLS | 2476 ± 521 | 1111 ± 234 | 8148 ± 1873 | 2048 ± 441 | 802 ± 172 | 428 ± 84 | 309 ± 87 |
Lethally irradiated (10.5 Gy) CD45.2 mice received transplants of 3 different doses (400, 1000, and 5000) of KTLS cells that corresponded with T-cell-depleted bone marrow cell doses used in Table 2 (eg, 400 KTLS = 8 × 105 T-cell-depleted bone marrow cells) from the congenic CD45.1 mice. Peripheral blood was harvested at various time points after stem cell transplantation. The blood samples were then stained and analyzed by flow cytometry. The absolute counts were determined using Flow-Count fluorospheres. Data represent absolute count (mean ± SD/μL blood) in peripheral blood from 4 to 15 animals per group per time point. All B cells were donor origin (Figure 2). KTLS indicates c-Kit+Thy1.1lowLin−/lowSca-1+ hematopoietic stem cells; —, not done. CD45.2 mice indicates C57BL/6, CD45.2, Thy1.2 mice. CD45.1 mice indicates C57BL/Ka, CD45.1, Thy1.1 mice.
P < .05, in any one of the following comparisons: 400 KTLS versus 1000 KTLS, 400 KTLS versus 5000 KTLS, and 1000 KTLS versus 5000 KTLS.
P < .05, any 2 of the following comparisons: 400 KTLS versus 1000 KTLS, 400 KTLS versus 5000 KTLS, and 1000 KTLS versus 5000 KTLS.
P < .05, all of the following comparisons: 400 KTLS versus 1000 KTLS, 400 KTLS versus 5000 KTLS, and 1000 KTLS versus 5000 KTLS.